These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2635684)

  • 21. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease.
    Joshua FF; Oakley SP; Major GA
    Intern Med J; 2004 Apr; 34(4):153-61. PubMed ID: 15086694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug prescription patterns for rheumatic disorders in Sweden.
    Bjelle A; Mjörndal T
    J Rheumatol; 1984 Aug; 11(4):493-9. PubMed ID: 6434737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of NSAIDs in rheumatic disorders 2005: a global perspective.
    Kean WF; Buchanan WW
    Inflammopharmacology; 2005; 13(4):343-70. PubMed ID: 16354389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of non-steroidal anti-inflammatory drugs on the pharmacokinetics and elimination of aciclovir in rats.
    Gwak HS; Oh JH; Han HK
    J Pharm Pharmacol; 2005 Mar; 57(3):393-8. PubMed ID: 15807996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methoxypropriocin in the treatment of inflammatory and degenerative diseases of the locomotor system].
    Tkaczewski W; Adamska-Dyniewska H; Goch JH; Dziekański S; Kowalczyk L; Szeszko A; Rec A
    Pol Tyg Lek; 1976 Mar; 31(9):371-2. PubMed ID: 1083512
    [No Abstract]   [Full Text] [Related]  

  • 27. [Comparative effectiveness of acetylsalicylic acid, naprosyn and their combinations with prednisolone in the treatment of inactive rheumatism].
    Gritsiuk AI; Vitruk SK; Kreminskaia IK; Brizinskiĭ MA
    Vrach Delo; 1984 Mar; (3):62-5. PubMed ID: 6609488
    [No Abstract]   [Full Text] [Related]  

  • 28. [Brufen on the eve of the 21st century].
    Karateev DE
    Ter Arkh; 1998; 70(12):78-80. PubMed ID: 10067261
    [No Abstract]   [Full Text] [Related]  

  • 29. Old and new pharmaceutical non-steroidal compounds prescribed for the management of patients with rheumatic diseases.
    Miehlke K
    Rheumatol Rehabil; 1979; Suppl():97-8. PubMed ID: 312524
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
    Williams GW; Kivitz AJ; Brown MT; Verburg KM
    Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of naprosin on the clinical picture and selected biochemical parameters in degenerative diseases of the peripheral joints].
    Bernacka K; Tytman K; Sierakowski S
    Wiad Lek; 1983 Oct; 36(20):1689-94. PubMed ID: 6670266
    [No Abstract]   [Full Text] [Related]  

  • 32. Current nonsteroidal anti-inflammatory drug applications for rheumatic diseases.
    Kantor TG
    Prim Care; 1993 Dec; 20(4):955-63. PubMed ID: 8310091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug therapy in rheumatology].
    Miehle W
    Fortschr Med; 1982 Sep; 100(36):1652-60. PubMed ID: 6292062
    [No Abstract]   [Full Text] [Related]  

  • 34. [Nonsteroidal antirheumatic agents--present status and perspectives].
    Curković B
    Reumatizam; 2000; 47(2):7-10. PubMed ID: 11552613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered pharmacokinetics of zalcitabine by concurrent use of NSAIDs in rats.
    Oh YH; Han HK
    Acta Pharmacol Sin; 2006 Jan; 27(1):119-22. PubMed ID: 16364218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
    Zacharowski P; Breese E; Wood E; Del Soldato P; Warner T; Mitchell J
    Eur J Pharmacol; 2005 Jan; 508(1-3):7-13. PubMed ID: 15680249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis.
    Schneeweiss S; Solomon DH; Wang PS; Rassen J; Brookhart MA
    Arthritis Rheum; 2006 Nov; 54(11):3390-8. PubMed ID: 17075817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of non-steroidal anti-inflammatory drugs on cell proliferation and death in cultured epiphyseal-articular chondrocytes of fetal rats.
    Chang JK; Wu SC; Wang GJ; Cho MH; Ho ML
    Toxicology; 2006 Dec; 228(2-3):111-23. PubMed ID: 17045721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [NSAIDs: a clinical pharmacological determination of their role in the drug treatment of rheumatic disorders].
    van Riel PL
    Ned Tijdschr Geneeskd; 1988 Nov; 132(48):2187-92. PubMed ID: 3264601
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspirin, NSAIDs, and cardiovascular risk: is there a link?
    Kapoor JR
    Am J Med; 2008 Nov; 121(11):e9. PubMed ID: 18954833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.